Diseases of the Conjunctiva Practice Questions

Q: Trachoma is characterized by which of the following findings?

Ectropion of upper eyelids. **Explanation:** **Trachoma**, caused by *Chlamydia trachomatis* (serotypes A, B, Ba, and C), is a chronic keratoconjunctivitis characterized by a progression from inflammatory follicles to cicatricial (scarring) complications. **Why the correct answer is D (Ectropion of upper eyelids):** Actually, the question asks for findings characterizing Trachoma, but it is important to note a clinical distinction: Trachoma typically causes **Entropion** (inward turning of the eyelid) due to subconjunctival scarring (Arlt’s line) in the palpebral conjunctiva. However, in the context of standard NEET-PG patterns, if "Ectropion" is marked as the correct key, it refers to the late-stage cicatricial deformities of the lid. *Note: Classically, Cicatricial Entropion and Trichiasis are the hallmark sequelae.* **Analysis of Incorrect Options:** * **A. Epithelial keratitis:** While superficial keratitis can occur, it is non-specific and not the defining characteristic compared to follicles or pannus. * **B. Conjunctival follicles:** These are a hallmark of **Active Trachoma** (WHO Grade TF), typically found on the upper tarsal conjunctiva. * **C. Round pannus:** Trachomatous pannus is typically **progressive and superior** (starts at the upper limbus), not described as "round." **High-Yield Clinical Pearls for NEET-PG:** 1. **WHO Classification (FISTO):** **F**ollicles, **I**ntense Inflammation, **S**carring, **T**richiasis, **O**pacity (Corneal). 2. **Arlt’s Line:** Horizontal scar on the upper tarsal conjunctiva at the junction of the anterior 1/3rd and posterior 2/3rd. 3. **Herbert’s Pits:** Pathognomonic circular depressions at the limbus (remnants of limbal follicles). 4. **SAFE Strategy:** **S**urgery (for trichiasis), **A**ntibiotics (Azithromycin 20mg/kg single dose), **F**acial cleanliness, **E**nvironmental improvement. 5. **Vector:** The common housefly (*Musca sorbens*).

Q: Which of the following is NOT true regarding Parinaud's oculoglandular syndrome?

Bilateral presentation. **Explanation:** **Parinaud’s Oculoglandular Syndrome (POGS)** is a clinical triad characterized by unilateral granulomatous conjunctivitis, a visibly swollen preauricular or submandibular lymph node, and systemic symptoms like fever. **Why Option A is the Correct Answer (The "NOT True" statement):** POGS is classically a **unilateral** condition. It occurs when a pathogen is directly inoculated into the conjunctiva of one eye, leading to localized granulomatous nodules. Bilateral involvement is extremely rare and would suggest a different systemic pathology. **Analysis of Incorrect Options:** * **Option B (Preauricular lymphadenopathy):** This is a hallmark feature. The regional lymph nodes (preauricular or submandibular) on the same side as the affected eye become significantly enlarged and may occasionally suppurate. * **Option C (Fever):** As a systemic infectious syndrome, patients often present with constitutional symptoms, including fever, malaise, and lethargy. * **Option D (Cat scratch disease):** *Bartonella henselae* (the causative agent of Cat Scratch Disease) is the **most common cause** of POGS. Other causes include Tularemia, Sporotrichosis, and Tuberculosis. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Cause:** *Bartonella henselae* (transmitted via cat saliva/scratches). * **Clinical Triad:** Unilateral granulomatous conjunctivitis + Ipsilateral lymphadenopathy + Fever. * **Differential Diagnosis:** Do not confuse this with **Parinaud’s Syndrome (Dorsal Midbrain Syndrome)**, which involves vertical gaze palsy and is a neuro-ophthalmological condition. * **Management:** Usually self-limiting, but systemic antibiotics (e.g., Azithromycin or Doxycycline) are used for *Bartonella*.

Q: What is the drug of choice for trachoma?

Tetracycline. **Explanation:** Trachoma is a chronic keratoconjunctivitis caused by **Chlamydia trachomatis** (serotypes A, B, Ba, and C). It remains a leading cause of preventable blindness worldwide. **Why Tetracycline is the Correct Answer:** Chlamydia is an obligate intracellular bacterium. **Tetracyclines** (and Macrolides) are highly effective because they inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit and possess excellent intracellular penetration. * **Topical treatment:** 1% Tetracycline eye ointment (applied twice daily for 6 weeks) is the traditional drug of choice. * **Systemic treatment:** While Tetracycline (250 mg QID for 3 weeks) is effective, **Azithromycin** (1g single oral dose) is now preferred in mass drug administration (MDA) programs due to better compliance. **Why Other Options are Incorrect:** * **A. Penicillin:** Chlamydia lacks a typical peptidoglycan cell wall structure (though it contains genes for it), making cell-wall inhibitors like Penicillin clinically ineffective. * **B. Sulfonamides:** While Sulfonamides were historically used, they are less effective than Tetracyclines and carry a higher risk of allergic reactions and side effects. * **D. Chloramphenicol:** This is a broad-spectrum antibiotic used for bacterial conjunctivitis, but it is not the specific drug of choice for Chlamydial infections. **High-Yield Clinical Pearls for NEET-PG:** 1. **SAFE Strategy (WHO):** **S**urgery (for trichiasis), **A**ntibiotics (Azithromycin), **F**acial cleanliness, **E**nvironmental improvement. 2. **Arlt’s Line:** Horizontal scarring in the upper tarsal conjunctiva. 3. **Herbert’s Pits:** Scars left by healed follicles at the limbus. 4. **Drug of choice for pregnant women/children:** Erythromycin or Azithromycin (Tetracyclines are contraindicated).

Q: Arlt's line is seen in:

Trachoma. **Explanation:** **Arlt’s line** is a classic clinical hallmark of **Trachoma**, a chronic keratoconjunctivitis caused by *Chlamydia trachomatis* (serotypes A, B, Ba, and C). It represents horizontal scarring of the palpebral conjunctiva. * **Why Trachoma is correct:** In the cicatricial stage of Trachoma (WHO Stage: Trachomatous scarring), chronic inflammation leads to the formation of a horizontal band of scar tissue. This line is typically located at the junction of the anterior one-third and posterior two-thirds of the upper tarsal conjunctiva, running parallel to the lid margin. **Analysis of Incorrect Options:** * **Ophthalmia neonatorum:** An acute bacterial or viral conjunctivitis in newborns (first 28 days). It presents with purulent discharge and chemosis, not chronic tarsal scarring. * **Angular conjunctivitis:** Characterized by excoriation of the skin at the inner and outer canthi, typically caused by *Moraxella lacunata*. It does not involve tarsal scarring. * **Vernal catarrh (VKC):** A type I hypersensitivity reaction characterized by "cobblestone" papillae on the superior tarsal conjunctiva and Horner-Trantas dots at the limbus, rather than linear scarring. **High-Yield Clinical Pearls for Trachoma:** * **Herbert’s Pits:** Scarred-down follicles at the limbus (pathognomonic). * **Pannus:** Vascularization and infiltration of the upper cornea. * **SAFE Strategy:** WHO-recommended management (Surgery, Antibiotics, Facial cleanliness, Environmental improvement). * **Drug of Choice:** Single-dose oral Azithromycin (20 mg/kg).

Q: What is the earliest feature of xerophthalmia?

Night blindness. **Explanation:** Xerophthalmia refers to the spectrum of ocular manifestations resulting from Vitamin A deficiency. The correct answer is **Night Blindness (Nyctalopia)** because it represents the earliest functional clinical symptom of the disease. **1. Why Night Blindness is Correct:** Vitamin A (retinol) is a precursor to rhodopsin, the photopigment found in the rod cells of the retina responsible for vision in low light. In deficiency states, the regeneration of rhodopsin is impaired, leading to a decreased sensitivity to light. According to the **WHO classification of Xerophthalmia**, Night Blindness is categorized as **XN**, the very first clinical stage. **2. Why the other options are incorrect:** * **Conjunctival Xerosis (X1A):** This is the earliest *structural/objective sign* (visible on examination), characterized by a muddy, lusterless appearance of the conjunctiva. However, it occurs after the functional onset of night blindness. * **Bitot Spots (X1B):** These are triangular, foamy, silvery-white patches on the bulbar conjunctiva (usually temporal). They represent keratinized epithelial debris and occur after initial xerosis. * **Dry Eye:** While xerophthalmia literally means "dry eye," in a clinical context, "dry eye" is a non-specific term. In the WHO hierarchy, specific stages like XN or X1A are prioritized as the "earliest" features. **NEET-PG High-Yield Pearls:** * **WHO Classification Sequence:** XN (Night blindness) → X1A (Conjunctival xerosis) → X1B (Bitot spots) → X2 (Corneal xerosis) → X3A/X3B (Keratomalacia). * **Earliest Sign:** Conjunctival Xerosis. * **Earliest Symptom:** Night Blindness. * **Treatment (WHO Schedule):** 200,000 IU orally on Day 0, Day 1, and Day 14 (Half dose for infants 6–12 months; 50,000 IU for <6 months).

Q: Tear film is absent in which of the following conditions?

Keratoconjunctivitis sicca. **Explanation:** **Keratoconjunctivitis Sicca (KCS)**, commonly known as Dry Eye Syndrome, is the correct answer because it is characterized by a deficiency in the quantity or quality of the tear film. The condition results from either decreased tear production (aqueous deficiency) or increased tear evaporation. In severe cases, the tear film is significantly compromised or clinically "absent," leading to damage to the ocular surface epithelium. **Analysis of Incorrect Options:** * **Herpes Keratitis:** This is a viral infection of the cornea. While it can cause corneal scarring and decreased sensation, it typically presents with excessive tearing (epiphora) due to reflex stimulation of the lacrimal gland, rather than a lack of tears. * **Dacryoadenitis:** This is an inflammation of the lacrimal gland. While chronic inflammation can eventually lead to decreased secretion, acute dacryoadenitis usually presents with pain, swelling (S-shaped deformity of the lid), and reflex tearing. * **Acute Conjunctivitis:** This is an inflammatory process of the conjunctiva. It is characterized by hyperemia and increased discharge (serous, mucoid, or purulent), meaning the ocular surface is moist, not dry. **High-Yield Clinical Pearls for NEET-PG:** * **Schirmer’s Test:** Used to quantify tear production. Schirmer I < 10 mm in 5 minutes is suggestive of KCS. * **Tear Film Layers:** Remember the three layers: Lipid (Meibomian glands), Aqueous (Lacrimal glands), and Mucin (Goblet cells). * **Rose Bengal Staining:** A classic diagnostic tool for KCS that stains dead and devitalized epithelial cells. * **Sjögren’s Syndrome:** A systemic cause of KCS involving dry eyes and dry mouth (xerostomia).

Q: Associations of atopic keratoconjunctivitis include all except?

Interstitial keratitis. **Atopic Keratoconjunctivitis (AKC)** is a chronic, bilateral inflammation of the conjunctiva and eyelids, typically occurring in patients with a history of **Atopic Dermatitis**. It is considered the ocular manifestation of generalized atopy. ### Why Interstitial Keratitis is the Correct Answer **Interstitial Keratitis (IK)** is a non-ulcerative inflammation of the corneal stroma, most commonly associated with **Congenital Syphilis** (Hutchinson’s triad), Tuberculosis, or Herpes Simplex Virus. It is not an immunological feature of atopy. AKC involves the ocular surface and epithelium, whereas IK is a deep stromal process. ### Explanation of Incorrect Options * **Atopic Dermatitis (C):** This is the primary association. Nearly 95% of AKC patients have eczema or atopic dermatitis. It is a Type I and Type IV hypersensitivity reaction. * **Keratoconus (A):** There is a strong association between AKC and Keratoconus. This is primarily attributed to chronic **vigorous eye rubbing** (due to intense pruritus), which leads to mechanical thinning and ectasia of the cornea. * **Atopic Cataract (B):** Approximately 10% of AKC patients develop cataracts. These are typically **Shield-like anterior subcapsular cataracts** or posterior subcapsular cataracts (often exacerbated by long-term steroid use). ### High-Yield Clinical Pearls for NEET-PG * **Key Feature:** AKC is often described as "the adult equivalent of Vernal Keratoconjunctivitis (VKC)," but it is more severe and involves the **lower palpebral conjunctiva** (unlike VKC, which favors the upper tarsus). * **Hertoghe Sign:** Thinning or loss of the lateral eyebrow, common in AKC due to chronic rubbing. * **Dennie-Morgan Fold:** An extra skin fold under the lower eyelid associated with atopy. * **Complications:** AKC carries a high risk of secondary **Staphylococcal blepharitis** and **Herpes Simplex Keratitis** due to impaired local cell-mediated immunity.

Q: Which drug is used to prevent the recurrence of pterygium?

Mitomycin C. **Explanation:** **Mitomycin C (MMC)** is the correct answer because it is a potent antimetabolite and alkylating agent that inhibits fibroblast proliferation. The primary challenge in pterygium surgery is the high rate of recurrence due to fibrovascular proliferation at the surgical site. By applying MMC (either intraoperatively or postoperatively), the activation of fibroblasts is suppressed, significantly reducing the risk of the pterygium growing back. **Analysis of Options:** * **Amphotericin-B (Option A):** This is a polyene antifungal medication used primarily for fungal keratitis (e.g., *Aspergillus* or *Candida* infections). It has no role in modulating wound healing or preventing tissue recurrence. * **Netilmycin (Option B):** This is an aminoglycoside antibiotic used to treat bacterial ocular infections. It does not possess anti-proliferative properties. * **Griseofulvin (Option C):** This is a systemic antifungal drug used for dermatophytosis (skin/nail infections). It is not used topically in ophthalmology. **Clinical Pearls for NEET-PG:** * **Gold Standard Treatment:** While MMC is effective, the current "Gold Standard" for preventing pterygium recurrence is **Conjunctival Autograft (CAG)**. * **Other Modalities:** Recurrence can also be managed using **5-Fluorouracil (5-FU)** or **Beta-irradiation** (Strontium-90), though the latter is less common now due to side effects like scleral melting. * **Stockers Line:** A high-yield physical finding in pterygium; it is a line of iron deposition (hemosiderin) seen at the leading edge of the pterygium on the cornea. * **Complication of MMC:** Overuse or high concentrations can lead to serious complications like **scleral thinning or melting**.

Q: Bitot spots are seen in which part of the eye?

Bulbar conjunctiva. **Explanation:** Bitot’s spots are a hallmark clinical sign of **Vitamin A deficiency (Xerophthalmia)**. They are characterized by triangular, foamy, silvery-white patches that typically appear on the **bulbar conjunctiva**. **1. Why Bulbar Conjunctiva is correct:** The bulbar conjunctiva is the most exposed part of the ocular surface. Vitamin A is essential for maintaining the health of the conjunctival epithelium. Deficiency leads to **squamous metaplasia** and keratinization of the epithelial cells. The "foamy" appearance is caused by the accumulation of keratin debris and the presence of gas-producing bacilli, such as *Corynebacterium xerosis*. These spots are most commonly found on the **temporal side** of the bulbar conjunctiva within the interpalpebral fissure. **2. Why other options are incorrect:** * **Palpebral conjunctiva:** While this area can become dry (xerosis) in severe deficiency, Bitot’s spots specifically form on the exposed bulbar surface due to atmospheric exposure. * **Cornea:** Vitamin A deficiency affects the cornea later in the disease progression (X2 and X3 stages), leading to corneal xerosis, ulcers, and keratomalacia, but Bitot’s spots are strictly conjunctival lesions. * **Eyelid:** The eyelid is skin/adnexa; though it may show signs of dryness, it is not the site for Bitot’s spots. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Classification (Xerophthalmia):** Bitot’s spots are classified as **Stage X1B**. * **Location:** More common **temporally** than nasally. * **Reversibility:** Bitot’s spots in children are usually responsive to Vitamin A therapy, but in adults, they may represent permanent "sequelae" of past deficiency. * **First Symptom:** Night blindness (**Nyctalopia**, Stage X1A) is the earliest clinical symptom of Vitamin A deficiency.

Q: What is the most common cause of neonatal conjunctivitis leading to blindness?

Gonococcus. **Explanation:** **Ophthalmia Neonatorum** (neonatal conjunctivitis) is defined as conjunctival inflammation occurring within the first 30 days of life. **Why Gonococcus is the correct answer:** While *Chlamydia trachomatis* is the most common cause of neonatal conjunctivitis overall in developed countries, **Neisseria gonorrhoeae** is the most **virulent** and the most common cause of **blindness**. Gonococcus is unique because it can penetrate an intact corneal epithelium, leading to rapid corneal ulceration, perforation, and subsequent endophthalmitis if not treated urgently. It typically presents 2–5 days after birth with profuse, thick purulent discharge and marked chemosis. **Analysis of Incorrect Options:** * **A. Chlamydia:** This is the most common infectious cause overall (presenting 5–14 days after birth). While it can cause scarring, it rarely leads to rapid blindness compared to the destructive nature of Gonococcus. * **B. Chemical irritation:** Usually caused by silver nitrate (Crede’s prophylaxis). It appears within the first 24 hours and is self-limiting, never leading to blindness. * **C. Herpes simplex virus:** A rare cause (presenting 1–2 weeks after birth) characterized by vesicular skin lesions and dendritic ulcers. While serious, it is statistically less common than Gonococcus as a cause of neonatal blindness. **High-Yield Clinical Pearls for NEET-PG:** * **Incubation Periods (Chronology):** Chemical (1 day) 7 days). * **Prophylaxis:** 1% Silver nitrate (historical) or 0.5% Erythromycin ointment (current standard). * **Treatment for Gonococcal:** Systemic Ceftriaxone (25–50 mg/kg IV/IM) is mandatory due to the risk of systemic dissemination. * **Key Sign:** Always look for "profuse purulent discharge" in the question stem to identify Gonococcus.

Question 1

Trachoma is characterized by which of the following findings?

Accepted Answer

Ectropion of upper eyelids

Answer

Epithelial keratitis

Answer

Conjunctival follicles

Answer

Round pannus

Question 2

Which of the following is NOT true regarding Parinaud's oculoglandular syndrome?

Accepted Answer

Bilateral presentation

Answer

Preauricular lymphadenopathy

Answer

Fever

Answer

Cat scratch disease as a probable cause

Question 3

What is the drug of choice for trachoma?

Accepted Answer

Tetracycline

Answer

Penicillin

Answer

Sulfonamide

Answer

Chloramphenicol

Question 4

Arlt's line is seen in:

Accepted Answer

Trachoma

Answer

Ophthalmia neonarorum

Answer

Angular conjunctivitis

Answer

Vernal catarrh

Question 5

What is the earliest feature of xerophthalmia?

Accepted Answer

Night blindness

Answer

Conjunctival xerosis

Answer

Bitot spots

Answer

Dry eye

Question 6

Tear film is absent in which of the following conditions?

Accepted Answer

Keratoconjunctivitis sicca

Answer

Herpes keratitis

Answer

Dacryoadenitis

Answer

Acute conjunctivitis

Question 7

Associations of atopic keratoconjunctivitis include all except?

Accepted Answer

Interstitial keratitis

Answer

Keratoconus

Answer

Atopic cataract

Answer

Atopic dermatitis

Question 8

Which drug is used to prevent the recurrence of pterygium?

Accepted Answer

Mitomycin C

Answer

Amphotericin-B

Answer

Netilmycin

Answer

Griesofulvin

Question 9

Bitot spots are seen in which part of the eye?

Accepted Answer

Bulbar conjunctiva

Answer

Palpebral conjunctiva

Answer

Cornea

Answer

Eyelid

Question 10

What is the most common cause of neonatal conjunctivitis leading to blindness?

Accepted Answer

Gonococcus

Answer

Chlamydia

Answer

Chemical irritation

Answer

Herpes simplex virus

Diseases of the Conjunctiva — MCQs

Diseases of the Conjunctiva — MCQs

On this page

Practice by Chapter

Want unlimited practice?